Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/MD/Hagerstown
Updated July 2026 from ClinicalTrials.gov

Paid Clinical Trials in Hagerstown, MD

Studies commonly pay $75 to $4,500 per completed study

112 clinical trials are currently recruiting participants within 30 miles of Hagerstown. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

112studies recruiting
9+research centers nearby
3condition categories
Live from the NIH registry

Studies recruiting near Hagerstown right now

Top 25 of 112 recruiting studies, sorted by proximity — each links to its official registry page

A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)

Neovascular Age-related Macular Degeneration Phase 4 Interventional 188 participants sought
Cumberland Valley Retina Consultants PC — Hagerstown, Maryland (0.1 mi) · Sponsor: Genentech, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT04853251)

A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic Atrophy

Geographic Atrophy, Macular Degeneration N/A Observational 500 participants sought
Cumberland Valley Retina Consultants,P.C. — Hagerstown, Maryland (0.1 mi) · Sponsor: Astellas Pharma Global Development, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06779773)

A Study to Evaluate Efficacy and Safety of MELT-300 for Procedural Sedation in Subjects Undergoing Cataract Extraction With Lens Replacement (CELR)

Cataract Phase 3 Interventional 528 participants sought
Maryland Vision Institute — Hagerstown, Maryland (0.1 mi) · Sponsor: Melt Pharmaceuticals
See eligibility & contact on ClinicalTrials.gov (NCT06383273)

Syringe Service Based Telemedicine and Social Network Driven HIV Prevention Service Implementation

HIV Infections, Substance Use Disorders N/A Interventional 360 participants sought
Frederick County Health Department, Street Safe Program — Frederick, Maryland (22.8 mi) · Sponsor: Johns Hopkins University
See eligibility & contact on ClinicalTrials.gov (NCT06103370)

Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial

Plasma Cell Myeloma, RISS Stage I Plasma Cell Myeloma Phase 3 Interventional 1,450 participants sought
Frederick Memorial Hospital — Frederick, Maryland (22.8 mi) · Sponsor: ECOG-ACRIN Cancer Research Group
See eligibility & contact on ClinicalTrials.gov (NCT04566328)

Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer

Advanced Endometrial Carcinoma, Recurrent Endometrial Carcinoma Phase 3 Interventional 255 participants sought
WVUH-Berkely Medical Center — Martinsburg, West Virginia (18.1 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT07198074)

A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy

Breast Cancer, Early Breast Cancer Phase 3 Interventional 4,300 participants sought
Research Site — Frederick, Maryland (22.8 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT05774951)

A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

Ovarian Carcinoma N/A Interventional 1,956 participants sought
WVUH-Berkely Medical Center — Martinsburg, West Virginia (18.1 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT04251052)

Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS)

Neovascular Age-Related Macular Degeneration (nAMD), Wet AMD Phase 3 Interventional 284 participants sought
Adverum Clinical Site 197 — Hagerstown, Maryland (0.1 mi) · Sponsor: Adverum Biotechnologies, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07482176)

A Study to Evaluate the Efficacy and Safety of Orally Administered VX-01

Diabetic Retinopathy, NPDR - Non Proliferative Diabetic Retinopathy Phase 2 Interventional 100 participants sought
Cumberland Valley Retina Consultants — Hagerstown, Maryland (0.1 mi) · Sponsor: Vantage Biosciences Ltd
See eligibility & contact on ClinicalTrials.gov (NCT06770933)

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

Breast Carcinoma, Colorectal Carcinoma N/A Observational 2,000 participants sought
WellSpan Medical Oncology and Hematology — Chambersburg, Pennsylvania (20.8 mi) · Sponsor: Wake Forest University Health Sciences
See eligibility & contact on ClinicalTrials.gov (NCT06418204)

Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer

Non-small Cell Lung Cancer Phase 2, Phase 3 Interventional 1,260 participants sought
Frederick Health Hospital- James M Stockman Cancer Institute — Frederick, Maryland (22.8 mi) · Sponsor: BioNTech SE
See eligibility & contact on ClinicalTrials.gov (NCT06712316)

A Phase 2 Efficacy and Safety Study of GAL-101, 2% Ophthalmic Solution in Non-foveal Geographic Atrophy Secondary to Non-neovascular AMD

Geographic Atrophy of the Macula Phase 2 Interventional 110 participants sought
Cumberland Valley Retina Consultants — Hagerstown, Maryland (0.1 mi) · Sponsor: Galimedix Therapeutics Inc
See eligibility & contact on ClinicalTrials.gov (NCT06659549)

A Study to Evaluate the Efficacy and Safety of OTX-TKI (Axitinib Implant) in Participants With Non-Proliferative Diabetic Retinopathy

Non-Proliferative Diabetic Retinopathy Phase 3 Interventional 930 participants sought
Cumberland Valley Retina Consultants — Hagerstown, Maryland (0.1 mi) · Sponsor: Ocular Therapeutix, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07235085)

A Safety and Efficacy Study of a One-time Intravitreal Injection of SAR446597 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration

Geographic Atrophy Phase 1, Phase 2 Interventional 104 participants sought
Cumberland Valley Retina Consultants - Hagerstown- Site Number : 8400003 — Hagerstown, Maryland (0.1 mi) · Sponsor: Sanofi
See eligibility & contact on ClinicalTrials.gov (NCT07215234)

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

Stage I Breast Cancer Phase 3 Interventional 1,670 participants sought
Chambersburg Hospital — Chambersburg, Pennsylvania (20.8 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT04852887)

Cognitive Training for Cancer Related Cognitive Impairment in Breast Cancer Survivors

Breast Cancer, Cognitive Impairments N/A Interventional 386 participants sought
Frederick Memorial Hospital — Frederick, Maryland (22.8 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT05896189)

Surabgene Lomparvovec Administered in the Suprachoroidal Space in Adult Participants With Diabetic Retinopathy Without Center-Involved Diabetic Macular Edema

Diabetic Retinopathy Phase 2, Phase 3 Interventional 576 participants sought
Mid Atlantic Retina Specialists - Hagerstown /ID# 274725 — Hagerstown, Maryland (0.1 mi) · Sponsor: AbbVie
See eligibility & contact on ClinicalTrials.gov (NCT07592273)

Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas

Intracranial Meningioma, Recurrent Meningioma Phase 2 Interventional 124 participants sought
WVUH-Berkely Medical Center — Martinsburg, West Virginia (18.1 mi) · Sponsor: Alliance for Clinical Trials in Oncology
See eligibility & contact on ClinicalTrials.gov (NCT02523014)

A Dose-masked Study of Intravitreal EYE103 in Participants With NVAMD or Macular Edema Following BRVO

Neovascular Age-Related Macular Degeneration (NVAMD), Branch Retinal Vein Occlusion (BRVO) Phase 2 Interventional 160 participants sought
Hagerstown, Maryland — Hagerstown, Maryland (0.1 mi) · Sponsor: EyeBiotech Ltd.
See eligibility & contact on ClinicalTrials.gov (NCT07205887)

Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS

Acute Coronary Syndrome Phase 3 Interventional 2,000 participants sought
Research Site — Chambersburg, Pennsylvania (20.8 mi) · Sponsor: DalCor Pharmaceuticals
See eligibility & contact on ClinicalTrials.gov (NCT05918861)

Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small Cell Lung Cancer, The RAPTOR Trial

Extensive Stage Lung Small Cell Carcinoma Phase 2, Phase 3 Interventional 138 participants sought
Chambersburg Hospital — Chambersburg, Pennsylvania (20.8 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT04402788)

Testing if High Dose Radiation Only to the Sites of Brain Cancer Compared to Whole Brain Radiation That Avoids the Hippocampus is Better at Preventing Loss of Memory and Thinking Ability

Metastatic Lung Small Cell Carcinoma, Metastatic Malignant Neoplasm in the Brain Phase 3 Interventional 200 participants sought
Chambersburg Hospital — Chambersburg, Pennsylvania (20.8 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT04804644)

A Study to Test Whether BI 1815368 Helps People With an Eye Condition Called Diabetic Macular Edema

Macular Edema Phase 2 Interventional 300 participants sought
Cumberland Valley Retina Consultants — Hagerstown, Maryland (0.1 mi) · Sponsor: Boehringer Ingelheim
See eligibility & contact on ClinicalTrials.gov (NCT06962839)
Google-rated

Top-rated research centers in Hagerstown

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

The Osteoporosis & Clinical Trials Center

346 Mill St, Hagerstown, MD 21740
(301) 791-6680

JOHNS HOPKINS UNIVERSITY COMSTOCK RESEARCH CENTER

★ 5.0
1100 Dual Hwy, Hagerstown, MD 21740
(301) 791-1847
"Quality Education Resources!!!"
— Roul, 5★

Meritus Medical Center

★ 2.3
11116 Medical Campus Rd, Hagerstown, MD 21742
(301) 790-8000
"It’s been years since I’ve been to Meritus. But wow it’s changed for the good. When I arrived to the ER on July 7th my health and pain were priority …"
— Christina Jenkins, 5★

Emerson Clinical Research Institute

★ 4.7
1718 Connecticut Ave NW, Washington, DC 20009
(202) 239-0777
"10/10 Vengan a Emerson Clinic que Wendy y Eliana son amables y tienen tanta paciencia para atenderlos. La clínica tiene recursos que ayudan y el doct…"
— Luis Mejia, 5★

Velocity Clinical Research

★ 4.1 (43 reviews)
1201 Seven Locks Rd Ste 214, Rockville, MD 20854
(240) 698-2800
"This place stay away from do not come here for a clinical research they will try to and will rip you off on paying you completely for your visits the…"
— Wanda Banville, 1★

DelRicht Research of Bethesda Clinical Trials

★ 4.5
6000 Executive Blvd Ste 315B, Rockville, MD 20852
(504) 336-2667
"Like others have mentioned, a complete waste of time, since they do not screen well enough beforehand. They told me they are NOT medical professional…"
— Chris Stott, 1★

Clinicaltrialmd.com

★ 5.0
2014 S Tollgate Rd Ste 207, Bel Air, MD 21015
(410) 670-3076
"Wonderful staff and easy testing. Overall, a good experience!"
— Julia, 5★

CenExel Gaithersburg MD

★ 4.6
9318 Gaither Rd #220, Gaithersburg, MD 20877
(301) 251-4702
"I’ve been with this company for 10 years and it’s a wonderful experience"
— Isaac Golden, 5★

MedStar Health Research Institute

★ 4.0
10980 Grantchester Wy 7th Floor, Columbia, MD 21044
(301) 560-7300
"Excelente personal muy amables"
— Glenda Hernandez, 5★

Clinical trials in Hagerstown: what's recruiting

The Hagerstown area currently has 112 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Hagerstown, the most active research areas are:

  • Cancer & Oncology11 studies
  • Heart & Vascular3 studies
  • Diabetes & Metabolism3 studies

Every listing shows the study phase, the recruiting site and its distance from Hagerstown, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Hagerstown

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Hagerstown participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Hagerstown pay?
Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.
Do I need to be sick to join a clinical trial in Hagerstown?
No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.
Are clinical trials in Hagerstown safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
How do I join a study in Hagerstown, MD?
Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.
How often do new paid studies open in Hagerstown?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Hagerstown.

Paid clinical trials near Hagerstown

Other metros within reach

Frederick, MD261 Arlington, VA2,345 Washington, DC2,376 Alexandria, VA2,303 York, PA459 Harrisburg, PA412 Baltimore, MD1,648 Fredericksburg, VA34

More of MD

Baltimore1,648 Frederick261

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts